0001209191-22-018820.txt : 20220315 0001209191-22-018820.hdr.sgml : 20220315 20220315162717 ACCESSION NUMBER: 0001209191-22-018820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valamehr Bahram CENTRAL INDEX KEY: 0001748177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 22741472 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-14 0 0001434316 FATE THERAPEUTICS INC FATE 0001748177 Valamehr Bahram C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 0 1 0 0 Chief R&D Officer Common Stock 2022-03-14 4 M 0 25000 2.73 A 204834 D Common Stock 2022-03-14 4 S 0 16678 30.36 D 188156 D Common Stock 2022-03-14 4 S 0 3067 31.66 D 185089 D Common Stock 2022-03-14 4 S 0 2195 32.49 D 182894 D Common Stock 2022-03-14 4 S 0 2960 33.30 D 179934 D Common Stock 2022-03-14 4 S 0 100 34.04 D 179834 D Stock Option (Right to Buy) 2.73 2022-03-14 4 M 0 25000 0.00 D 2027-01-04 Common Stock 25000 36156 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020. Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5. Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share. Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share. Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share. This option is fully vested. /s/ Cindy Tahl, as Attorney-in-Fact 2022-03-15